Drug Delivery Nanotechnology Market Trends: Liposomes and Nanocarriers Drive Targeted Treatment
Market Overview According to MarketGenics, the global Drug Delivery Nanotechnology Market was valued at USD 98.2 billion in 2025 and is projected to reach USD 214.4 billion by 2035, registering a CAGR of 8.1% during the forecast period of 2026–2035. The market is expanding as pharmaceutical and biotechnology companies increasingly adopt nanotechnology-based delivery systems to improve drug bioavailability, enable targeted treatment, control drug release, and reduce unwanted effects on healthy tissues. Liposomes account for approximately 32% of the market, supported by their biocompatibility, efficient drug encapsulation, and ability to deliver different types of therapeutic compounds. Growing applications in cancer treatment, infectious diseases, chronic disease management, RNA therapeutics, and gene therapy are further accelerating market growth. Advances in lipid nanoparticles, polymeric nanoparticles, and precision medicine are creating new opportunities for next-generation...